These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2004-003783-30 Application of Aprepitant as salvage prophylaxis after failure of a conventional antiemetic therapy during moderately emetogenic chemotherapy in gastrointestinal cancer 2006-10-15 due-trials
Ongoing 2004-004024-12 Efficacy of the EGFR antibody Cetuximab in combination with weekly Oxaliplatin/5FU/Folinsäure (AIO-FUFOX) in advanced gastro-oesophageal adenocarcinoma not-yet-due
Not reported 2005-000967-24 Evaluation of Response Rate to Pre-operative Docetaxel + Herceptin study part A and Docetaxel study part B In Locally Advanced Breast Cancer Patients, Stratified by HER2-Status, Trial Phase II 2014-05-07 due-trials
Not reported 2005-000986-20 The CORE Study (Chemotherapy or Endocrine Treatment first?) 2007-07-31 due-trials
Not reported 2005-001278-28 Untersuchungen über die Wirkung der gestörten Glucosetoleranz auf die renale und systemische Hämodynamik und das renin-Angiotensin-System sowie deren pharmakologische Beeinflussung mittels AT1-Rezepto... 2006-10-20 due-trials
Ongoing 2005-001415-21 Phase II Studie zur Evaluierung der SH U 555 C unterstützten Magnetresonanztomographie der arteriosklerotischen Karotisstenose bei Patienten vor Thrombendarteriektomie not-yet-due
Completed, but no date 2005-003013-32 PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED; MULTICENTER TRIAL OF BIVALIRUDIN AND UN-FRACTIONATED HEPARIN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS bad-data
Ongoing 2005-003196-21 Enhancing the Therapeutic Efficacy of Sleep Deprivation by Modafinil - a double blind, randomized, placebo-controlled, monocentric phase II study not-yet-due
Completed, but no date 2005-003832-24 An open, prospective, randomized, comparative study to evaluate the effect of Iodixanol 320 compared to Iomeprol 350 on contrast medium induced nephropathy in patients with impaired renal function und... bad-data
Not reported 2005-004123-19 Metabolic Response Evaluation for an Individualization of Neoadjuvant Chemo- and Radiotherapy in Esophageal Adenocarcinoma 2014-04-17 due-trials
Not reported 2005-005313-38 Somatostatin_octretide for prevention of rebleeding from gastrointestinal angiodysplasias 2008-09-11 due-trials
Not reported 2006-000368-10 High-dose therapy with Esomeprazol in combination with Baclofen therapy for symptomatic therapy-resistant gastrooesophageal reflux disease. 2008-10-11 due-trials
Not reported 2006-000369-12 An open, randomized, single-center study assessing the serum time-concentration curves and the effect of prophylactic moxifloxacin (in comparison with cefuroxime) on the early inflammatory response to... 2011-03-16 due-trials
Ongoing 2006-000811-12 A Randomised Phase II/III trial of peri-operative Chemotherapy with or without Bevacizumab in Operable Oesophagogastric Adenocarcinoma and A Feasibility Study Evaluating Lapatinib in HER-2 Positive Oe... not-yet-due
Not reported 2006-001097-24 Phase I/II study of continous infusion with 5-FU and weekly Oxaliplatin / Cetuximab combined with concurrent radiation as neoadjuvant treatment in locally advanced oesophageal squamous cell carcinoma. 2015-08-13 due-trials
Not reported 2006-002085-19 PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, MULTICENTER TRIAL OF ABCIXIMAB AND BIVALIRUDIN IN PATIENTS WITH NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONAR... 2012-04-24 due-trials
Not reported 2006-002886-38 A Multicenter Study on Regenerative Effects of Erythropoitin (LDE) in Burn and Scaled Injuries 2014-06-06 due-trials
Not reported 2006-003115-49 Einsatz von Mycophenolsäure (Myfortic) bei antikörpervermittelten immunologischen Erkrankungen: Effekt auf Krankheitsverlauf und Organfunktionsparameter 2010-12-24 due-trials
Not reported 2006-003819-45 PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ERYTHROPOIETIN IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION. REVIVAL-3 (... 2009-03-09 due-trials
Completed, but no date 2006-004122-90 Levofloxacin vs Piperacillin/Sulbactam and Sultamicillin in patients with bacterial cholangitis. A double blind, randomiized study. bad-data
Ongoing 2006-004434-32 Prevention of postoperative delirium with donepezil not-yet-due
Ongoing 2006-006137-41 Prospective, randomized, open, 2-arm national multi-center study to evaluate the value of Rituximab in humoral chronic rejection after renal transplantation not-yet-due
Not reported 2007-000502-70 An open-label phase I/II (proof of concept) trial of an combination of Nilotinib (AMN 107) and RAD001 in patients with acute myeloid leukemia 2012-06-29 due-trials
Not reported 2007-005116-12 Phase II study of the mTOR-Inhibitor EVEROLIMUS as 2012-10-08 due-trials
Not reported 2007-005865-37 Levofloxacin vs Piperacillin/Sulbactam and Sultamicillin in patients with acute cholecystitis. A double blind, randomized study. 2012-05-16 due-trials
Not reported 2007-006263-68 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF 6 MONTHS VERSUS 12 MONTHS CLOPIDOGREL THERAPY AFTER IMPLANTATION OF A DRUG-ELUTING STENT 2016-06-14 due-trials
Not reported 2008-000815-13 Analysis of cerebral, renal, peripheral, and retinal hemodynamics in adults with type 2 diabetes before, during, and after administration of pioglitazone or placebo. 2010-12-01 due-trials
Ongoing 2008-001560-37 Sequentielle Kombination einer Chemotherapie mit Gemcitabine/Oxaliplatin und photodynamischen Therapie beim fortgeschrittenen Gallengangskarzinom not-yet-due
Completed, but no date 2008-002130-30 Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with Non-Small Cell Lung Cancer (NSCLC) after radiochemotherapy (RCT) bad-data
Not reported 2008-002721-37 An open-label, uncontrolled phase II trial of HDAC inhibitor LBH589 in patients with chemo-refractory metastatic gastric cancer overexpressing histone deacetylases - CLBH589BDE03T 2013-02-25 due-trials
Not reported 2008-003331-20 Effect of quetiapine XR on sleep in patients with major depression, as compared with mirtazapine 2010-04-22 due-trials
Not reported 2008-008239-27 Dosisfindungsstudie Sugammadex und Neostigmin bei geringer neuromuskulärer Restblockade (Sugammadex and Neostigmine dose finding study for reversal of residual neuromuscular blockade) 2009-07-11 due-trials
Listed as ongoing, but also has a completion date 2009-012031-15 Efficacy of early antipsychotic switch versus maintenance in patients with schizophrenia poorly responding to two weeks of antipsychotic treatment 2014-02-06 bad-data
Ongoing 2009-012815-16 Dosis-Wirkungsstudie von Rocuronium unter Propofol-Anästhesie (Rocuronium Dose Finding Study after single shot or steady state propofol anesthesia) not-yet-due
Ongoing 2009-013499-29 Dosisfindungsstudie für Sugammadex und Neostigmin zur Reversierung einer geringen neuromuskulären Restblockade (train of four ratio 0,2) [Sugammadex and Neostigmine dose finding study for reversal of ... not-yet-due
Ongoing 2009-014582-51 Pilot study - sequential combination therapy using selective immunoglobulin apheresis and omalizumab in patients with severe atopic dermatitis and elevated total IgE levels not-yet-due
Completed, but no date 2009-014641-88 Phase I/II dose-escalation study of the investigational trifunctional bispecific anti-CD20 x anti-CD3 antibody FBTA05 in combination with donor lymphocyte infusion (DLI) in patients with CD20 positive... bad-data
Not reported 2009-015410-22 A multicenter, randomized, double-blind study with 2 groups as prove of concept for the treatment of ACE induced angioedema with subcutaneous Icatibant 2011-12-01 due-trials
Ongoing 2009-017085-22 Sugammadex improves muscle function after standard neuromuscular recovery (SIMAR) [Verbesserung der Muskelfunktion durch Sugammadex nach normaler neuromuskulärer Erholung] not-yet-due
Completed, but no date 2010-018559-84 AMBITIOUS Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage Single- arm trial to identify potential markers underlying variability in response to Omalizumab (Xolair®) treatment in a... bad-data
Completed, but no date 2010-021139-15 Do Selective Radiation Dose Escalation and Tumor Hypoxia Status Impact the Locoregional Tumor Control after Radiochemotherapy of Head & Neck Tumors? bad-data
Not reported 2010-022570-13 Gadovit-Studie 2013-06-13 due-trials
Not reported 2011-000503-40 DABI-ADP-1: 2012-09-19 due-trials
Not reported 2011-000504-18 DABI-ADP-2: 2014-05-01 due-trials
Completed, but no date 2011-000815-15 BOSTRIP bad-data
Ongoing 2011-001686-40 INTRACORONARY STENTING AND ANTITHROMBOTIC REGIMEN: ADJUSTING ANTIPLATELET TREATMENT IN PATIENTS BASED ON PLATELET FUNCTION TESTING - ISAR ADAPT-PF not-yet-due
Not reported 2011-002544-27 Prospective, explorative trial for the detection of circulating cell-free tumor DNA in the plasma of patients with gastrointestinal stromal tumors (GIST) harboring activating mutations of CKIT or PDGF... 2015-10-14 due-trials
Reported results 2011-004396-36 Phase III randomized sequential open-label study to evaluate the efficacy and safety of sorafenib followed by pazopanib versus pazopanib followed by sorafenib in the treatment of advanced / metastatic... 2016-11-14 due-trials
Completed, but no date 2012-001670-28 Angiotensin Converting Enzyme Inhibitor (ACE) Induced Angioedema bad-data
Completed, report not yet due 2012-003630-16 A Randomized, Parallel Group, Double-Blind Study of Ticagrelor Compared with Aspirin for Prevention of Vascular Events in Patients Undergoing Coronary Artery Bypass Graft Operation TiCAB– Ticagrelor i... 2019-05-07 not-yet-due
Ongoing 2013-002272-40 PROSPECTIVE, RANDOMIZED TRIAL OF TICAGRELOR VERSUS PRASUGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME not-yet-due
Completed, but no date 2014-000860-16 Metabolic and Molecular Response Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction bad-data
Completed, report not yet due 2014-005287-15 - PRE-POINT-EARLY STUDY - Pilot study using oral insulin at early age for immune efficacy in primary prevention of type 1 diabetes 2017-12-21 not-yet-due
Completed, but no date 2015-000360-34 DUALIS bad-data
Ongoing 2015-000686-32 Revacept, a novel inhibitor of platelet adhesion in patients with stable coronary artery disease undergoing elective percutaneous coronary interventions: A phase II, multicentre, randomised, dose-fin... not-yet-due
Ongoing 2015-000762-65 Single-arm study to assess a potential effect of anti-IL-17 (Secukinumab) in the treatment of pyoderma gangrenosum not-yet-due
Ongoing 2015-003028-30 Fr1da Insulin Intervention - Mechanistic study using oral insulin for immune efficacy in secondary prevention of type 1 diabetes not-yet-due
Ongoing 2015-003379-31 An immune efficacy study for primary prevention using intranasal insulin therapy in islet autoantibody negative children at high genetic risk for type 1 diabetes not-yet-due
Ongoing 2015-005219-34 Parenteral Nutrition during neoadjuvant chemotherapy for patients with advanced gastric or advanced gastroesophageal cancer for reduction of postoperative morbiditiy not-yet-due
Ongoing 2016-001313-24 SUbstition of PERioperative Albumin Deficiency Disorders not-yet-due
Ongoing 2016-002351-16 An investigator-initiated, randomized, double-blind, placebo controlled study of Apremilast to demonstrate efficacy in subjects with nummular eczema not-yet-due
Ongoing 2016-005022-10 Improvement of synaptic plasticity and cognitive function in RAS pathway disorders not-yet-due
Ongoing 2017-000152-26 Intraoperative wound irrigation to prevent surgical site infection after not-yet-due
Other 2017-003088-36 GPPAD-POInT (Global Platform of Autoimmune Diabetes – Primary Oral Insulin Trial) not-yet-due